Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Guardant Health Liquid Biopsy Test Gets Draft LCD for Most Advanced Solid Tumors

Guardant Health Liquid Biopsy Test Gets Draft LCD for Most Advanced Solid Tumors

Mar 28, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA has proposed coverage for Guardant Health's 73-gene Guardant360 liquid biopsy test in more than a dozen solid tumor types where biomarker information is needed to inform their treatment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Extension Call

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

All Along the Axon

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

For the Accelerator

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

Science Papers Describe New Cas9 Variant, Atlas of Human Metabolism

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. FDA Fleshes Out Emergency Guidance for Coronavirus Test Developers

  2. Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

  3. Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

  4. BGI Americas Gets US Emergency Use Authorization for Coronavirus Test

  5. Thermo Fisher Scientific COVID-19 Test Receives CE Mark, Expanded FDA EUA

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.